Caslake R, Macleod A, Ives N, Stowe R, Counsell C. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease. Cochrane Database Syst Rev 2009; (4): CD006661.
Chen F, Jin L, Nie Z. Safety and Efficacy of Rotigotine for Treating Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials. J Pharm Pharm Sci 2017; 20: 285-294.
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014; 311(16): 1670-1683.
Deutsche Gesellschaft für Neurologie (DGN). Idiopathisches Parkinson-Syndrom (S3-Leitlinie). AWMF-Registernr.: 030-010. January 2016. (Leitlinien für Diagnostik und Therapie in der Neurologie).
Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009; 373(9680): 2055-2066.
PD Med Collaborative Group, Gray R, Ives N, Rick C, Patel S, Gray A et al. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet 2014; 384(9949): 1196-1205.
Stowe R, Ives N, Clarke CE, Deane K, van Hilten J, Wheatley K et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications. Cochrane Database Syst Rev 2010; (7): CD007166.
Stowe R, Ives N, Clarke CE, van Hilten J, Ferreira J, Hawker RJ et al. Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev 2008; (2): CD006564.
Wang HT, Wang L, He Y, Yu G. Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials. J Neurol Sci 2018; 393: 31-38.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.